ARTICLE | Company News
Kinetek, atugen GeneBloc deal
February 20, 2002 8:00 AM UTC
atugen (Berlin, Germany) will use its GeneBloc and cellular delivery technologies to knock-down the expression of signal transduction kinase targets supplied by Kinetek (Vancover, B.C.). Kinetek then ...